Full Coverage

Rigel Pharmaceuticals announces financial results for the third quarter of 2009

news-medical.net
Nov 3, 2009
 
Story Timeline:  24 days

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the third quarter and nine months ended September 30, 2009. For the third quarter of 2009, Rigel reported a net loss of $26.7 million, or $0.70 per... [read full story]                    

powered by
Add Comment
Latest article on this story:

Rigel reports $26.7M loss in Q3

 smartbrief.com Nov 3, 2009
First article on this story:

Rigel Announces Third Quarter 2009 Financial Results

 prnewswire.com Nov 3, 2009
Selected publications with coverage of this story:
news-medical.net prnewswire.com bizjournals.com yahoo.com smartbrief.com
RELATED
Found 6 documents:

Rigel reports $26.7M loss in Q3

smartbrief.com
Nov 3, 2009
 

San Francisco Business Times - by lost $26.7 million, down from a loss of $37.7 million in the same quarter a year earlier. That works out to a per-share loss of 70 cents, down from a loss of $1.03 a share in the third quarter...

powered by

Rigel reports $26.7M loss in Q3

bizjournals.com
Nov 3, 2009
 

San Francisco Business Times - by lost $26.7 million, down from a loss of $37.7 million in the same quarter a year earlier. That works out to a per-share loss of 70 cents, down from a loss of $1.03 a share in the third quarter...

powered by
                   

Rigel 3Q loss narrows on lower costs

smartbrief.com
Nov 3, 2009
 

SOUTH SAN FRANCISCO, Calif. - Rigel Pharmaceuticals Inc. said Tuesday its third-quarter loss narrowed as the development-stage biotechnology company completed two midstage studies in its rheumatoid arthritis program.

powered by
                   

Rigel 3Q loss narrows on lower costs (AP)

yahoo.com
Nov 3, 2009
 

Rigel Pharmaceuticals' 3rd-quarter loss narrows on lower stock, development costs SOUTH SAN FRANCISCO, Calif. (AP) -- Rigel Pharmaceuticals Inc. said Tuesday its third-quarter loss narrowed as the development-stage...

powered by
                   

Rigel Announces Third Quarter 2009 Financial Results (PR Newswire)

yahoo.com
Nov 3, 2009
 

For the third quarter of 2009, Rigel reported a net loss of $26.7 million, or $0.70 per share, compared to a net loss of $37.7 million, or $1.03 per share, in the third quarter of 2008. For the nine months ended September 30,...

powered by
                   

Rigel Announces Third Quarter 2009 Financial Results

prnewswire.com
Nov 3, 2009
 

SOUTH SAN FRANCISCO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the third quarter and nine months ended September 30, 2009.

powered by